Skip to Content

475 (Imatinib Mesylate 400 mg)

Pill with imprint 475 is Yellow, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Sun Pharma Global FZE.

Imatinib is used in the treatment of gastrointestinal stromal tumor; chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans (and more), and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 475

Imatinib Mesylate

Imprint:
475
Strength:
400 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sun Pharma Global FZE
National Drug Code (NDC):
47335-0475

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide